<?xml version="1.0" encoding="UTF-8"?>
<OML_O21>
  <MSH>
    <MSH.1>|</MSH.1>
    <MSH.2>^~\&amp;#</MSH.2>
    <MSH.3>
      <MSH.3.1>NIST EHR</MSH.3.1>
    </MSH.3>
    <MSH.4>
      <MSH.4.1>NIST EHR Facility</MSH.4.1>
    </MSH.4>
    <MSH.5>
      <MSH.5.1>NIST Test Lab APP</MSH.5.1>
    </MSH.5>
    <MSH.6>
      <MSH.6.1>NIST Lab Facility</MSH.6.1>
    </MSH.6>
    <MSH.7>
      <MSH.7.1>20130211184101-0500</MSH.7.1>
    </MSH.7>
    <MSH.9>
      <MSH.9.1>OML</MSH.9.1>
      <MSH.9.2>O21</MSH.9.2>
      <MSH.9.3>OML_O21</MSH.9.3>
    </MSH.9>
    <MSH.10>NIST-LOI_8.0_1.1-NG</MSH.10>
    <MSH.11>
      <MSH.11.1>T</MSH.11.1>
    </MSH.11>
    <MSH.12>
      <MSH.12.1>2.5.1</MSH.12.1>
    </MSH.12>
    <MSH.15>AL</MSH.15>
    <MSH.16>AL</MSH.16>
    <MSH.21>
      <MSH.21.1>LOI_Common_Component</MSH.21.1>
      <MSH.21.2>LOI Base Profile</MSH.21.2>
      <MSH.21.3>2.16.840.1.113883.9.66</MSH.21.3>
      <MSH.21.4>ISO</MSH.21.4>
    </MSH.21>
    <MSH.21>
      <MSH.21.1>LOI_NG_Component</MSH.21.1>
      <MSH.21.2>LOI NG Profile</MSH.21.2>
      <MSH.21.3>2.16.840.1.113883.9.79</MSH.21.3>
      <MSH.21.4>ISO</MSH.21.4>
    </MSH.21>
    <MSH.21>
      <MSH.21.1>LAB_PRU_Component</MSH.21.1>
      <MSH.21.2>LOI PRU Profile</MSH.21.2>
      <MSH.21.3>2.16.840.1.113883.9.82</MSH.21.3>
      <MSH.21.4>ISO</MSH.21.4>
    </MSH.21>
  </MSH>
  <OML_O21.PATIENT>
    <PID>
      <PID.1>1</PID.1>
      <PID.3>
        <PID.3.1>PATID5678</PID.3.1>
        <PID.3.4>
          <PID.3.4.1>NIST MPI</PID.3.4.1>
        </PID.3.4>
        <PID.3.5>MR</PID.3.5>
      </PID.3>
      <PID.5>
        <PID.5.1>
          <PID.5.1.1>Vannatatu</PID.5.1.1>
        </PID.5.1>
        <PID.5.2>Yolanda</PID.5.2>
        <PID.5.3>G.</PID.5.3>
        <PID.5.7>L</PID.5.7>
      </PID.5>
      <PID.7>
        <PID.7.1>19281011</PID.7.1>
      </PID.7>
      <PID.8>F</PID.8>
      <PID.10>
        <PID.10.1>2076-8</PID.10.1>
        <PID.10.2>Native Hawaiian or Other Pacific Islander</PID.10.2>
        <PID.10.3>HL70005</PID.10.3>
      </PID.10>
      <PID.11>
        <PID.11.1>
          <PID.11.1.1>15006 Bloomquist Way</PID.11.1.1>
        </PID.11.1>
        <PID.11.2>Apt 4</PID.11.2>
        <PID.11.3>Huntington Park</PID.11.3>
        <PID.11.4>CA</PID.11.4>
        <PID.11.5>90255</PID.11.5>
        <PID.11.7>H</PID.11.7>
      </PID.11>
      <PID.22>
        <PID.22.1>H</PID.22.1>
        <PID.22.2>Hispanic</PID.22.2>
        <PID.22.3>HL70189</PID.22.3>
      </PID.22>
    </PID>
  </OML_O21.PATIENT>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-1</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>1</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-1</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>24323-8</OBR.4.1>
          <OBR.4.2>Comprehensive metabolic 2000 panel - Serum or Plasma</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>Comprehensive Metabolic profile</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240820-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-1</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>119364003</SPM.4.1>
            <SPM.4.2>Serum specimen (specimen)</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>SER</SPM.4.4>
            <SPM.4.5>Serum</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240820-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-2</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>2</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-2</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>57021-8</OBR.4.1>
          <OBR.4.2>CBC W Auto Differential panel in Blood</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>CBC W Auto Differential panel in Blood</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240825-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-2</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>119297000</SPM.4.1>
            <SPM.4.2>Blood Specimen</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>BLD</SPM.4.4>
            <SPM.4.5>Blood</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240825-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-3</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>3</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-3</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>59261-8</OBR.4.1>
          <OBR.4.2>Hemoglobin A1c/Hemoglobin.total in Blood</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>Hemoglobin A1c NGSP protocol in blood</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240825-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-2</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>119297000</SPM.4.1>
            <SPM.4.2>Blood Specimen</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>BLD</SPM.4.4>
            <SPM.4.5>Blood</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240825-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-4</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>4</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-4</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>1554-5</OBR.4.1>
          <OBR.4.2>Glucose [Mass/volume] in Serum or Plasma --12 hours fasting</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>Glucose 12 hr fasting</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240820-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.OBSERVATION>
        <OBX>
          <OBX.1>1</OBX.1>
          <OBX.2>CWE</OBX.2>
          <OBX.3>
            <OBX.3.1>49541-6</OBX.3.1>
            <OBX.3.2>Fasting status</OBX.3.2>
            <OBX.3.3>LN</OBX.3.3>
            <OBX.3.4>1902</OBX.3.4>
            <OBX.3.5>Fasting Status</OBX.3.5>
            <OBX.3.6>99USL</OBX.3.6>
          </OBX.3>
          <OBX.5>
            <OBX.5.1>Y</OBX.5.1>
            <OBX.5.2>Yes</OBX.5.2>
            <OBX.5.3>HL70136</OBX.5.3>
          </OBX.5>
          <OBX.11>O</OBX.11>
          <OBX.14>
            <OBX.14.1>20130124</OBX.14.1>
          </OBX.14>
          <OBX.29>SCI</OBX.29>
        </OBX>
      </OML_O21.ORDER.OBSERVATION_REQUEST.OBSERVATION>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-1</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>119364003</SPM.4.1>
            <SPM.4.2>Serum specimen (specimen)</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>SER</SPM.4.4>
            <SPM.4.5>Serum</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240820-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-5</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>5</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-5</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>24331-1</OBR.4.1>
          <OBR.4.2>Lipid 1996 panel in Serum or Plasma</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>Lipid 1996 panel in Serum or Plasma</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240825-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.OBSERVATION>
        <OBX>
          <OBX.1>1</OBX.1>
          <OBX.2>CWE</OBX.2>
          <OBX.3>
            <OBX.3.1>49541-6</OBX.3.1>
            <OBX.3.2>Fasting status</OBX.3.2>
            <OBX.3.3>LN</OBX.3.3>
            <OBX.3.4>1902</OBX.3.4>
            <OBX.3.5>Fasting Status</OBX.3.5>
            <OBX.3.6>99USL</OBX.3.6>
          </OBX.3>
          <OBX.5>
            <OBX.5.1>Y</OBX.5.1>
            <OBX.5.2>Yes</OBX.5.2>
            <OBX.5.3>HL70136</OBX.5.3>
          </OBX.5>
          <OBX.11>O</OBX.11>
          <OBX.14>
            <OBX.14.1>20130124</OBX.14.1>
          </OBX.14>
          <OBX.29>SCI</OBX.29>
        </OBX>
      </OML_O21.ORDER.OBSERVATION_REQUEST.OBSERVATION>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-2</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>119297000</SPM.4.1>
            <SPM.4.2>Blood Specimen</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>BLD</SPM.4.4>
            <SPM.4.5>Blood</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240825-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
  <OML_O21.ORDER>
    <ORC>
      <ORC.1>NW</ORC.1>
      <ORC.2>
        <ORC.2.1>ORD798642-6</ORC.2.1>
        <ORC.2.2>Lamaze EHR</ORC.2.2>
      </ORC.2>
      <ORC.4>
        <ORC.4.1>ORD798642</ORC.4.1>
        <ORC.4.2>Lamaze EHR</ORC.4.2>
      </ORC.4>
      <ORC.9>
        <ORC.9.1>20130124</ORC.9.1>
      </ORC.9>
      <ORC.12>
        <ORC.12.1>1238998979</ORC.12.1>
        <ORC.12.2>
          <ORC.12.2.1>Lamaze</ORC.12.2.1>
        </ORC.12.2>
        <ORC.12.3>Jerry</ORC.12.3>
        <ORC.12.9>
          <ORC.12.9.1>NPI</ORC.12.9.1>
        </ORC.12.9>
        <ORC.12.10>L</ORC.12.10>
        <ORC.12.13>NPI</ORC.12.13>
      </ORC.12>
      <ORC.14>
        <ORC.14.3>PH</ORC.14.3>
        <ORC.14.6>626</ORC.14.6>
        <ORC.14.7>9876543</ORC.14.7>
        <ORC.14.8>1</ORC.14.8>
      </ORC.14>
      <ORC.20>
        <ORC.20.1>2</ORC.20.1>
        <ORC.20.2>Patient has been informed of responsibility, and agrees to pay for service</ORC.20.2>
        <ORC.20.3>HL70339</ORC.20.3>
      </ORC.20>
    </ORC>
    <OML_O21.ORDER.OBSERVATION_REQUEST>
      <OBR>
        <OBR.1>6</OBR.1>
        <OBR.2>
          <OBR.2.1>ORD798642-6</OBR.2.1>
          <OBR.2.2>Lamaze EHR</OBR.2.2>
        </OBR.2>
        <OBR.4>
          <OBR.4.1>50564-4</OBR.4.1>
          <OBR.4.2>Urinalysis panel - Urine by Auto</OBR.4.2>
          <OBR.4.3>LN</OBR.4.3>
          <OBR.4.7>2.42</OBR.4.7>
          <OBR.4.9>Complete UA - Auto</OBR.4.9>
        </OBR.4>
        <OBR.7>
          <OBR.7.1>201301240840-0800</OBR.7.1>
        </OBR.7>
        <OBR.16>
          <OBR.16.1>1238998979</OBR.16.1>
          <OBR.16.2>
            <OBR.16.2.1>Lamaze</OBR.16.2.1>
          </OBR.16.2>
          <OBR.16.3>Jerry</OBR.16.3>
          <OBR.16.9>
            <OBR.16.9.1>NPI</OBR.16.9.1>
          </OBR.16.9>
          <OBR.16.10>L</OBR.16.10>
          <OBR.16.13>NPI</OBR.16.13>
        </OBR.16>
        <OBR.17>
          <OBR.17.3>PH</OBR.17.3>
          <OBR.17.6>626</OBR.17.6>
          <OBR.17.7>9876543</OBR.17.7>
          <OBR.17.8>1</OBR.17.8>
        </OBR.17>
      </OBR>
      <DG1>
        <DG1.1>1</DG1.1>
        <DG1.3>
          <DG1.3.1>E11.69</DG1.3.1>
          <DG1.3.2>Type 2 diabetes mellitus with other specified complication</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Diabetes mellitus type II</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>2</DG1.1>
        <DG1.3>
          <DG1.3.1>E78.5</DG1.3.1>
          <DG1.3.2>Hyperlipidemia, unspecified</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hyperlipidemia NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>2</DG1.15>
      </DG1>
      <DG1>
        <DG1.1>3</DG1.1>
        <DG1.3>
          <DG1.3.1>I10</DG1.3.1>
          <DG1.3.2>Essential (primary) hypertension</DG1.3.2>
          <DG1.3.3>I10C</DG1.3.3>
          <DG1.3.9>Hypertension, NOS</DG1.3.9>
        </DG1.3>
        <DG1.6>F</DG1.6>
        <DG1.15>3</DG1.15>
      </DG1>
      <OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
        <SPM>
          <SPM.1>1</SPM.1>
          <SPM.2>
            <SPM.2.1>
              <SPM.2.1.1>SP798642-3</SPM.2.1.1>
              <SPM.2.1.2>Lamaze EHR</SPM.2.1.2>
            </SPM.2.1>
          </SPM.2>
          <SPM.4>
            <SPM.4.1>258574006</SPM.4.1>
            <SPM.4.2>Midstream Urine</SPM.4.2>
            <SPM.4.3>SCT</SPM.4.3>
            <SPM.4.4>URMS</SPM.4.4>
            <SPM.4.5>Urine, midstream</SPM.4.5>
            <SPM.4.6>L</SPM.4.6>
          </SPM.4>
          <SPM.17>
            <SPM.17.1>
              <SPM.17.1.1>201301240840-0800</SPM.17.1.1>
            </SPM.17.1>
          </SPM.17>
        </SPM>
      </OML_O21.ORDER.OBSERVATION_REQUEST.SPECIMEN>
    </OML_O21.ORDER.OBSERVATION_REQUEST>
  </OML_O21.ORDER>
</OML_O21>
